Sterility concerns prompt recall of drugs from Fla. compounder

05/10/2013 | Modern Healthcare (subscription required)

The FDA warned pharmacists and doctors not to use treatments from The Compounding Shop, a specialty pharmacy in Florida, prompting it to notify customers and recall all of its sterile treatments. An inspection of the compounder raised concerns about sterility issues regarding its drugs that could cause bacterial contamination, the FDA said.

View Full Article in:

Modern Healthcare (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC